"In my view, these results are very, very slightly hopeful, but not more than this, " says John Hardy, a University College, London, neuroscientist and geneticist who was among the first to point to a link between amyloid, the protein bapineuzumab attacks, and Alzheimer's.
FORBES: Hope Mixes With Doubt For Alzheimer's